Close Menu

NEW YORK – Personalis reported after the close of the market on Thursday that its second quarter revenues rose 23 percent year over year, driven by a 74 percent increase in revenues from the analytical services it provided to the US Department of Veterans Affairs Million Veteran Program (VA MVP).

For the three months ended June 30, the cancer genomics company reported revenues of $19.5 million, up from $15.8 million a year earlier, and beating the average Wall Street estimate of $16.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.